Wang Jonathan Jian 4

What Happened Jonathan Jian Wang, a director of ImageneBio, was granted 15,600 derivative shares (reported as an "A" award) on 2026-06-16 at an acquisition price of $0.00. The reported transaction is an equity award under the company's incentive plan, not an open-market purchase or sale, so no cash changed hands.

Key Details

• Transaction date: 2026-06-16; Form 4 filed 2026-06-18 (timely filing).
• Award: 15,600 derivative shares; reported price $0.00; total reported value $0.
• Vesting: Shares vest in full upon the earlier of (a) first anniversary of the grant date, (b) the issuer’s next annual meeting, or (c) a change of control per the 2025 Equity Incentive Plan (per footnote).
• Shares owned after transaction: not specified in the provided filing.

Context This was a company equity award (likely restricted stock units or similar) issued as compensation to a director, which is routine and does not necessarily signal a personal market bet. Derivative awards vest on specified triggers (time/meeting/change of control), so the recipient cannot freely trade them until vesting conditions are met.